Labcorp Holdings Inc.
Bear Case (25th pct.)
-55.4% vs price
Base Case (Median)
-25.2% vs price
Bull Case (75th pct.)
-15.5% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $59.47 | -81.6% | High (40%) |
| PE Comparable | $269.05 | -16.8% | Medium (25%) |
| Growth Trajectory DCF | $378.35 | 17.0% | Medium (20%) |
| Graham Number | $167.88 | -48.1% | Medium (40%) |
| EV/EBITDA | $241.91 | -25.2% | Medium (20%) |
| EV/FCF | $277.69 | -14.1% | Medium (20%) |
| Earnings Power Value | $120.53 | -62.7% | Medium (50%) |
Based on 7 out of 8 methods, LH appears overvalued at the current price of $323.34. The base case fair value of $241.91 implies 25.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.